Trial Profile
Safety and tolerance clinical trial of amifampridine in patients with Lambert-Eaton myasthenic syndrome who have renal impairment
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 May 2014
Price :
$35
*
At a glance
- Drugs Amifampridine (Primary)
- Indications Lambert-Eaton myasthenic syndrome
- Focus Adverse reactions
- 27 May 2014 New trial record